CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. The company is headquartered in Hatfield, Pennsylvania. The company went IPO on 2023-08-23. Its products include HiRise, LineUp, PedCAT Premium, pedCAT, InReach, OssView, CubeVue Software, Autometrics, 3D Measurement Tools and Cloud. HiRise is a bilateral, weight-bearing CT imaging of the entire lower extremities including hips/pelvis and distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach is a point-of-care extremity CT imaging for the upper extremities and the non-weight bearing lower extremities. InReach HR-pQCT is a high-resolution peripheral quantitative CT (HR-pQCT) imaging designed for the point-of-care. OssView is a bone fragility software that analyzes HR-pQCT images at the distal radius to measure the bone microarchitecture.
How did CRVAF's recent EPS compare to expectations?
The most recent EPS for Curvebeam AI Ltd is $, expectations of $.
How did Curvebeam AI Ltd CRVAF's revenue perform in the last quarter?
Curvebeam AI Ltd revenue for the last quarter is $
What is the revenue estimate for Curvebeam AI Ltd?
According to of Wall street analyst, the revenue estimate of Curvebeam AI Ltd range from $ to $
What's the earning quality score for Curvebeam AI Ltd?
Curvebeam AI Ltd has a earning quality score of /. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Curvebeam AI Ltd report earnings?
Curvebeam AI Ltd next earnings report is expected in
What are Curvebeam AI Ltd's expected earnings?
Curvebeam AI Ltd expected earnings is $, according to wall-street analysts.
Did Curvebeam AI Ltd beat earnings expectations?
Curvebeam AI Ltd recent earnings of $ expectations.